Please sign in to follow a disease.

AQP4+ nmosd

Clinical trials for AQP4+ nmosd explained in plain language.

Never miss a new study

Get alerted when new AQP4+ nmosd trials appear

Sign up with your email to follow new studies for AQP4+ nmosd, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1 Not yet recruiting 1

New registry to monitor Real-World effects of NMOSD treatments

Knowledge-focused Recruiting now

This study is a long-term registry for adults with AQP4+ neuromyelitis optica spectrum disorder (NMOSD) who are already taking Alexion C5 inhibitor drugs like eculizumab or ravulizumab. It will collect information on relapses, safety, and quality of life over many years to unders…

Matched conditions: AQP4+ NMOSD

Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Knowledge-focused

Last updated Jun 27, 2026 14:00 UTC

AQP4+ nmosd

Get alerted when new AQP4+ nmosd trials appear

New registry to monitor Real-World effects of NMOSD treatments